EA200500082A1 - PHARMACEUTICAL COMPOSITION FOR INTERTRACIAL DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS - Google Patents

PHARMACEUTICAL COMPOSITION FOR INTERTRACIAL DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS

Info

Publication number
EA200500082A1
EA200500082A1 EA200500082A EA200500082A EA200500082A1 EA 200500082 A1 EA200500082 A1 EA 200500082A1 EA 200500082 A EA200500082 A EA 200500082A EA 200500082 A EA200500082 A EA 200500082A EA 200500082 A1 EA200500082 A1 EA 200500082A1
Authority
EA
Eurasian Patent Office
Prior art keywords
physiologically active
active agents
pharmaceutical composition
delivery
intertracial
Prior art date
Application number
EA200500082A
Other languages
Russian (ru)
Other versions
EA007351B1 (en
Inventor
Игорь Гонда
Тимоти Матиас Морган
Нина Франсис Уилкинс
Original Assignee
АКРУКС ДиДиЭс ПиТиУай ЭлТиДи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by АКРУКС ДиДиЭс ПиТиУай ЭлТиДи filed Critical АКРУКС ДиДиЭс ПиТиУай ЭлТиДи
Publication of EA200500082A1 publication Critical patent/EA200500082A1/en
Publication of EA007351B1 publication Critical patent/EA007351B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

В данном изобретении представлена фармацевтическая композиция для чрескожной доставки, содержащая один или более физиологически активных агентов, один или более агентов, способствующих проникновению через кожу, фармацевтически приемлемый носитель, содержащий летучий растворитель, а также гидрофторуглеродный пропеллент, причем комбинация носителя и агентов, способствующих проникновению, дает однофазный раствор одного или более физиологически активных агентов.Международная заявка была опубликована вместе с отчетом о международном поиске.The present invention provides a pharmaceutical composition for percutaneous delivery, containing one or more physiologically active agents, one or more agents that promote penetration through the skin, a pharmaceutically acceptable carrier containing a volatile solvent, and a hydrofluorocarbon propellant, and the combination of carrier and agents that promote penetration, gives a single phase solution of one or more physiologically active agents. The international application was published along with an international search.

EA200500082A 2002-06-25 2003-06-24 Pharmaceutical composition for transdermal delivery of physiologically active agents EA007351B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPS3171A AUPS317102A0 (en) 2002-06-25 2002-06-25 Transdermal aerosol compositions
PCT/AU2003/000784 WO2004000275A1 (en) 2002-06-25 2003-06-24 Transdermal aerosol compositions

Publications (2)

Publication Number Publication Date
EA200500082A1 true EA200500082A1 (en) 2005-06-30
EA007351B1 EA007351B1 (en) 2006-10-27

Family

ID=3836730

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200500082A EA007351B1 (en) 2002-06-25 2003-06-24 Pharmaceutical composition for transdermal delivery of physiologically active agents

Country Status (9)

Country Link
EP (1) EP1534241A1 (en)
JP (1) JP2005533795A (en)
KR (1) KR20050071373A (en)
AU (1) AUPS317102A0 (en)
BR (1) BR0312004A (en)
CA (1) CA2490325A1 (en)
EA (1) EA007351B1 (en)
NZ (1) NZ537435A (en)
WO (1) WO2004000275A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050045946A (en) * 2002-06-25 2005-05-17 애크럭스 디디에스 피티와이 리미티드 Transdermal delivery rate control using amorphous pharmaceutical compositions
JP2007511544A (en) * 2003-11-19 2007-05-10 アクルックス・ディ・ディ・エス・プロプライエタリー・リミテッド Compositions and methods for prevention or treatment of amyloidosis
US20060263421A1 (en) 2005-05-18 2006-11-23 Abeille Pharmaceuticals Inc Transdermal Method and Patch for Nausea
DK2219603T3 (en) * 2007-11-02 2014-09-01 Acrux Dds Pty Ltd TRANSDERMAL DELIVERY SYSTEM
EA022648B1 (en) * 2011-02-15 2016-02-29 Эли Лилли Энд Компани Methods for controlling pain in equines using a transdermal solution of fentanyl
ES2688288T3 (en) * 2011-02-15 2018-10-31 Elanco Us Inc. Procedures to control canine pain using a transdermal solution of fentanyl
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
WO2020212948A1 (en) 2019-04-17 2020-10-22 Compass Pathfinder Limited Methods of treating neurocognitive disorders, chronic pain and reducing inflammation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5082866A (en) * 1988-06-01 1992-01-21 Odontex, Inc. Biodegradable absorption enhancers
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US6004969A (en) * 1996-04-15 1999-12-21 National Science Council Transdermal delivery of buprenorphine preparations
ATE252380T1 (en) * 1999-02-05 2003-11-15 Cipla Ltd TOPICAL SPRAYS CONTAINING A FILM-FORMING COMPOSITION
IN191090B (en) * 2000-08-29 2003-09-20 Ranbanx Lab Ltd

Also Published As

Publication number Publication date
KR20050071373A (en) 2005-07-07
NZ537435A (en) 2006-02-24
WO2004000275A1 (en) 2003-12-31
EA007351B1 (en) 2006-10-27
JP2005533795A (en) 2005-11-10
BR0312004A (en) 2005-03-29
AUPS317102A0 (en) 2002-07-18
EP1534241A1 (en) 2005-06-01
CA2490325A1 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
ECSP055701A (en) NEW DERIVATIVES OF PYRIMIDINAMIDE AND THE USE OF THE SAME
CY1109364T1 (en) A COMBINATION CONTAINING COMBRETASTATIN AND ANTI-CANCER FACTORS
EA200500084A1 (en) PHARMACEUTICAL COMPOSITION FOR THE VACUUM DELIVERY OF AN ACTIVE AGENT
CY1112376T1 (en) 2,3,4,9-tetrahydro-1H-carvasol derivative as CRTH2 receptor antagonists
EA200600190A1 (en) DERIVATIVES OF PYRIMIDIN-2,4-DIONA AS ANTAGONISTS OF THE GONADOTROPYN-SURVIVER HORMONE RECEPTOR ANTAGONISTS
HK1080364B (en) Oral pharmaceutical forms of liquid drugs having improved bioavailability
PA8575701A1 (en) ACID INSULIN PREPARATIONS WITH IMPROVED STABILITY
EA200200571A1 (en) NEW COMPOSITION AND ITS APPLICATION
ATE554750T1 (en) PREPARATIONS CONTAINING HYDROPHOBIC PHARMACEUTICAL ACTIVE INGREDIENTS
SE0003449D0 (en) Anticancer compositions
BR0313343A (en) Use of a mixture of permeation agents, nail and periungual solutions and use of a nail and periungual solution
BRPI9917007B8 (en) azabicycloalkanes as ccr5 modulators, pharmaceutical composition containing them, as well as their use
EA200401526A1 (en) NEW CONNECTIONS AND THEIR APPLICATION
CY1111698T1 (en) COMBINATION INCLUDING AN AT1 COMPETITIVE RECEPTOR AND AN INSULIN EXTRACTOR OR A INSULIN SENSITIVE
HUP0100705A2 (en) Combination effective for the treatment of impotence
NO990833L (en) Pharmaceutical compounds
EA200500082A1 (en) PHARMACEUTICAL COMPOSITION FOR INTERTRACIAL DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS
DE50012571D1 (en) BIOTIN CONTAINING GALENIC FORMULATION
DE60142913D1 (en) DRUG SOLUTIONS CONTAIN MODAFINIL COMPOUNDS
ES2189252T3 (en) ANALGESIC COMPOSITIONS THAT INCLUDE AN ANTAGONIST OF THE COLECISTOQUININE AND AN OPIOID.
ECSP930933A (en) PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR PREPARING IT
NO20014855L (en) N- (2-phenyl-4-aminobutyl) -1-naphthamides as neurokinin-1 receptor antagonists
CO4940457A1 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING INSULIN SENSITIZERS FOR THE TREATMENT OF DIABETES
AR008154A1 (en) ACID (S) -7 - [(4,4'-BIPIPERIDIN-1-IL) CARBONYL] -2,3,4,5-TETRAHIDRO-4-METHYL--3-OXO-1H-1,4-BENZODIAZEPINE- 2-ACETICO, LIKE HYDROCHLORIDE OF THE SAME, A PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT, THE USE OF THE SAME AND A PROCEDURE FOR ITS PREPARATION.
EA200101106A1 (en) PHARMACEUTICAL COMPLEX

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU